308 related articles for article (PubMed ID: 7466310)
1. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
2. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B
Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398
[TBL] [Abstract][Full Text] [Related]
3. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
5. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
6. [ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma].
Terada H; Ohshima M
Rinsho Ketsueki; 1989 Jan; 30(1):22-8. PubMed ID: 2716195
[TBL] [Abstract][Full Text] [Related]
7. Platelet function in patients with high platelet counts.
Ginsburg AD
Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
[TBL] [Abstract][Full Text] [Related]
8. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
Hochhaus A; Mindner K; Ostermann G; Höche D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
[TBL] [Abstract][Full Text] [Related]
9. Platelet survival, platelet factor-4 and bleeding time in myeloproliferative disorders.
Berild D; Hasselbalch H; Knudsen JB
Scand J Clin Lab Invest; 1987 Sep; 47(5):497-501. PubMed ID: 3477851
[TBL] [Abstract][Full Text] [Related]
10. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
11. [Platelet defects in chronic myeloproliferative disorders].
Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
Yamamoto K; Sekiguchi E; Takatani O
Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
[TBL] [Abstract][Full Text] [Related]
13. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia.
Thiele J; Schneider G; Hoeppner B; Wienhold S; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):407-17. PubMed ID: 3140482
[TBL] [Abstract][Full Text] [Related]
14. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts?
Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL
Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056
[TBL] [Abstract][Full Text] [Related]
15. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
16. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
17. A review of myeloproliferative disease with presentation in the head and neck region.
Collins A
Ann R Australas Coll Dent Surg; 1998 Oct; 14():119-24. PubMed ID: 10895623
[TBL] [Abstract][Full Text] [Related]
18. Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay.
Koch CA; Lasho TL; Tefferi A
Br J Haematol; 2004 Oct; 127(1):34-9. PubMed ID: 15384975
[TBL] [Abstract][Full Text] [Related]
19. Platelet function studies in myeloproliferative disorders.
Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]